journal
MENU ▼
Read by QxMD icon Read
search

Pharmaceutical Patent Analyst

journal
https://www.readbyqxmd.com/read/29227204/canada-s-supreme-court-abolishes-promise-of-the-patent
#1
John Norman, Alex Gloor
The Supreme Court of Canada has done away with the 'promise of the patent' doctrine. This doctrine invalidated patents to numerous otherwise useful inventions from 2005 to 2016. The Supreme Court of Canada has clarified that the statutory utility requirement requires only a scintilla of utility related to the subject matter of the invention. This utility must have been demonstrated or soundly predicted as of the Canadian filing date. The decision brings increased certainty to Canada's patent system and more closely aligns it with international norms...
December 11, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227203/therapeutic-charm-of-quercetin-and-its-derivatives-a-review-of-research-and-patents
#2
Ajay Sharma, Dharambir Kashyap, Katrin Sak, Hardeep Singh Tuli, Anil K Sharma
Bioactive polyphenolic compounds derived from plants are being utilized for prevention of various chronic diseases including cancer and cardiovascular disorders. Quercetin, a potential poly-phenolic flavonol, found in onions, apples and berries, has been implicated against cancer proliferation, chronic inflammation and various other oxidative manifestations. Evidences suggested that quercetin negatively regulates the numerous crucial signaling pathways associated with life-threatening diseases. Major signaling pathways including NF-κB, MAPK, PI3K-AKT and mTOR are found to be regulated by quercetin...
December 11, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227198/novel-platinum-compounds-and-nanoparticles-as-anticancer-agents
#3
Arindam Sarkar
Since the approval of cisplatin in 1979, platinum-based drugs have been regularly used in cancer chemotherapy as a first-line treatment or with the combination of other nonplatinum drugs. Subsequent approval of second- and third-generation drugs such as carboplatin and oxaliplatin respectively, has widened the therapeutic achievement of platinum compounds. There are few other platinum drugs approved recently and many other new drugs as well as the formulations of the old ones are going through clinical trials now...
December 11, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227196/immunotherapeutics-for-the-treatment-of-prostate-cancer-a-patent-landscape-based-on-key-therapeutic-mechanisms-of-actions
#4
Elaine Harris
The area of immunotherapeutics for the treatment of metastatic castrate-resistant prostate cancer has made significant progress since the autologous cell-based vaccine sipuleucel T became the first and to date only immunotherapy for its treatment. This review focuses on a broad patent landscaping exercise of this therapeutic area and considers if basing this landscaping on key mechanisms of action is appropriate to elicit the main patenting trends.
December 11, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29219751/patent-highlights-august-september-2017
#5
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
December 8, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29064350/patenting-the-microbiome-trends-challenges-and-insights
#6
Anthony D Sabatelli, Nicholas G Vincent, David E Puleo
No abstract text is available yet for this article.
October 24, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29064331/patent-highlights-june-july-2017
#7
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
October 24, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022845/the-unified-patent-court-where-are-we-and-what-should-you-be-doing
#8
Rowan Freeland
The road to the Unified Patent Court, which will allow industry to enforce its patents in Europe in a single set of proceedings rather than in numerous national courts, is becoming increasingly rocky as the project approaches its goal. This article reviews the rocks encountered in the past year and looks forward to what industry now needs to be addressing as the summit approaches.
October 12, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022759/no-change-in-scope-for-extension-of-patent-term-for-pharmaceutical-substances-under-australian-law-an-update
#9
Malcolm Lyons, Amanda Stark
No abstract text is available yet for this article.
October 12, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022490/the-german-federal-supreme-court-also-granted-a-compulsory-patent-license-for-the-first-time-in-its-history
#10
Takeshi S Komatani
No abstract text is available yet for this article.
October 12, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022418/patent-protection-why-the-first-filing-needs-to-be-right-and-how-to-achieve-this
#11
Alexander Bajjon, George W Schlich
Patent rights are crucial value drivers for individuals and technology companies, large or small. This article presents the selection of best practice pointers under the law of the European Patent Office on how to get the most out of patent applications, especially the 'first filing' that establishes a priority date for and sets the framework for future patent rights.
October 12, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022415/doctrine-of-equivalents-in-japan-criteria-of-special-conditions-and-estoppel-final-conclusion
#12
Takeshi S Komatani
No abstract text is available yet for this article.
October 12, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28825514/patent-highlights-april-may-2017
#13
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
August 21, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28825509/pretargeting-immunotherapy-a-novel-treatment-approach-for-systemic-amyloidosis
#14
Jonathan S Wall, James S Foster, Emily B Martin, Stephen J Kennel
The amyloidoses are a complex group of disorders characterized by the deposition of proteinaceous amyloid fibrils in vital organs. The deposits are nonimmunogenic and may be composed of one of more than 35 proteins. We have developed a two-stage immunotherapeutic approach using peptides that recognize most, if not all, amyloid deposits to facilitate amyloid clearance. In the first embodiment, we have developed a bifunctional peptope to enhance and expand the utility of currently available antibodies. In the second, we have generated peptide-reactive antibodies that can be targeted to the amyloid deposits by peptides thereby providing alternative reagents for immunotherapy of amyloidosis...
August 21, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28818024/enforceability-of-second-medical-use-claims-in-the-uk
#15
Tom Carver
No abstract text is available yet for this article.
August 18, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28818023/pre-emptive-product-patentability-declarations
#16
Lorna Brazell
No abstract text is available yet for this article.
August 18, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28818005/computational-biology-future-challenges-for-the-patenting-of-repurposed-drugs
#17
Bruce Bloom
No abstract text is available yet for this article.
August 18, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28818001/pulmonary-drug-delivery-system-newer-patents
#18
Shahid Sukhbir Kaur
Inhalational route for drug delivery and desired effects has been known since centuries. This lung-targeted therapy has benefited asthmatics and those with chronic respiratory problems. The technique has evolved greatly from crude pots and pipes to modern sophisticated drug-dispensing devices. This mode is effective, rapid and safe. Its outcome, however, is majorly determined by drug formulation, device structure and patient's coordinating skill. In spite of great advances in this field, more efforts are required to meet the unmet needs...
August 18, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28696180/epithelial-na-channel-inhibitors-for-the-treatment-of-cystic-fibrosis
#19
Nichola J Smith, Catherine F Solovay
The epithelial Na(+) channel (ENaC) is a key regulator of the volume of airway surface liquid (ASL) and is found in the human airway epithelium. In cystic fibrosis (CF), Na(+) hyperabsorption through ENaC, in the absence of cystic fibrosis transmembrane conductance regulator mediated anion secretion, results in the dehydration of respiratory secretions and the impairment of mucociliary clearance. The hypothesis of utilizing an ENaC blocking molecule to facilitate restoration of the airway surface liquid volume sufficiently to allow normal mucociliary clearance is of interest in the management of lung disease in CF patients...
July 11, 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/28696178/a-cheat-sheet-to-navigate-the-complex-maze-of-pharmaceutical-exclusivities-in-europe
#20
Marta Cavero Tomas, Bo Peng
As the two leading markets for pharmaceutical and biotech companies, the USA and Europe offer incentives to stimulate drug innovation, including patent and regulatory exclusivities. These exclusivities extend periods during which companies can market their products free of generic or other competition and recoup their investment. Pharmaceutical and biotech companies should carefully assess the different types of exclusivities available when developing regulatory submissions, patent filing strategies. The authors have previously summarized the USA exclusivities in an earlier publication...
July 11, 2017: Pharmaceutical Patent Analyst
journal
journal
47821
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"